Akèy › Metiyè › Medical Scientists, Except Epidemiologists › Durham, NC
Medical Scientists, Except Epidemiologists nan Durham, NC: Salè H-1B
89 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Durham, NC. Salè baz medyàn ofri $67,210; mwatye mitan $61,998–$74,327.
Demann (LCA)89
Salè medyan ofri$67,210
Mwatye salè yo$61,998–$74,327
10yèm–90yèm pousantaj$56,489–$117,610
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $62,000 |
| Nivo II (kalifye) | $72,100 |
| Nivo III (eksperyans) | $132,256 |
| Nivo IV (plen kompetans) | $178,500 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Duke University | 62 | $65,000 |
| Tergus Pharma, LLC | 3 | $70,000 |
| RTI Health Solutions, LLC | 3 | $118,729 |
| Duke University Health System | 2 | $63,744 |
| ICF Incorporated, LLC | 2 | $95,702 |
| Duke University and Health System | 2 | $60,250 |
| Research Triangle Institute (U.S.) | 2 | $107,455 |
| Creyon Bio, Inc. | 2 | $178,500 |
| Guidehouse Digital LLC | 2 | $90,176 |
| AstraZeneca Pharmaceuticals LP | 1 | $125,372 |
| Sarepta Therapeutics, Inc. | 1 | $72,000 |
| Glioblastoma Foundation Inc. | 1 | $55,224 |
| United Therapeutics Corporation | 1 | $149,513 |
| Laboratory Corporation of America Holdings | 1 | $179,442 |
| Physicians Committee for Responsible Medicine | 1 | $115,000 |
| Novartis Pharmaceuticals Corporation | 1 | $99,757 |
| KBI Biopharma, Inc. | 1 | $85,904 |
| MedPharm Manufacturing Services LLC | 1 | $80,247 |
Tit travay
- Postdoctoral Associate26
- Research Associate Senior12
- Research Associate, Sr11
- Research Scholar5
- Research Scientist4
- Scientist II, Analytical R&D3
- Lab Research Analyst, Senior3
- Research Health Outcomes Scientist 23
- Assistant Professor2
- House Staff Resident, Clinical2
- Senior Research Associate2
- Director Translational Medicine2
- Technical Senior Analyst2
- Senior Scientist1
- Senior Toxicologist1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).